Author

Taylor Coleman

Ambry Genetics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:database / resource· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Abby V. McGeeiD· 1 shared Abbye E. McEweniD· 1 shared Alan F. RubiniD· 1 shared Allyssa J. VandiiD· 1 shared Carina G BiariD· 1 shared Daniel L. HolmesiD· 1 shared Daniel ZeibergiD· 1 shared Douglas M. FowleriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Abby V. McGeeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

An integrated, scaled approach to resolve TSC2 variants of uncertain significance

Carina G Biar, Ziyu R. Wang, Nathan D. Camp, Daniel L. Holmes, Melinda K. Wheelock, Sriram Pendyala, Abby V. McGee, Pankhuri Gupta, Abbye E. McEwen, Malvika Tejura, Marcy E. Richardson, Jamie D. Weyandt, Taylor Coleman, Alan F. Rubin, Nick Moore, , Jeffrey Dennis Calhoun

Abundance scores for 8,891 TSC2 missense variants, plus mTOR pathway activity scores for 391, were calibrated to ACMG/AMP evidence. They putatively reclassify 212 of 276 clinical-cohort missense VUS.

Nature Communications · Jul 9, 2026Peer-reviewedGenetics✦ In-depth digest